Nogo-A affected amyloid deposition and the formation of dystrophic neurites by negatively regulating BACE1 activity, thereby affecting the metabolism of Aβ and triggering the occurrence and development of Alzheimer's disease [54]. Here, BACE1 is linked to early-onset autosomal dominant Alzheimer disease.